Friedewald S, Rafferty E, Rose S, et al. (2014). Breast Cancer Screening Using Tomosynthesis in Combination with
Digital Mammography. Journal of the American Medical Association (JAMA), 311(24), 2499-2507
Zuley M, Bandos A, Ganott M, et al. “Digital Breast Tomosynthesis versus Supplemental Diagnostic
Mammographic Views for Evaluation of Noncalcified Breast Lesions.” Radiology. 2013 Jan; 266(1):89-95.
Skaane P, Bandos A, Gullien R, et al. “Comparison of Digital Mammography Alone and Digital Mammography
Plus Tomosynthesis in a Population-based Screening Program.” Radiology. 2013 Apr; 267(1):47-56.
Rose S, Tidwell A, Bujnock L, et al. “Implementation of Breast Tomosynthesis in a Routine Screening Practice: An
Observational Study.” American Journal of Roentgenology. 2013 Jun; 200(6): 1401-1408.
Brodersen J, Siersma V. “Long-Term Psychosocial Consequences of False-Positive Screening Mammography.”
The Annals of Family Medicine 2013 Mar;11(2):106-15.
Yaghjyan L, Colditz GA, Collins LC, et al. Mammographic breast density and subsequent risk of breast cancer in
postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011;103(15):1179-1189.
Bertrand KA, Tamimi RM, Scott CG, et al. Mammographic density and risk of breast cancer by age and tumor
characteristics. Breast Cancer Res. 2013;15(6):R104.
FDA. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/
FDA PMA submission P080003/S001 physician labelling.
Bernardi D, Pellegrini M, Valentini M et al. “The STORM II (Screening with Tomosynthesis or Mammography II)
Trial: Interim Comparison of Screen-reading Strategies in Population Breast Screening.” (paper presented at the
annual meeting of the Radiological Society of North America, Chicago, Il, December 2014).
Durand M, Raghu M, Geisel J, et al. “Synthesized 2D Mammography + Tomosynthesis: Can We See Clearly?”
(paper presented at the annual meeting of the Radiological Society of North America, Chicago, Il, December
Choi J, Han B, Ko E, et al. “Comparison with Two-Dimensional Synthetic Mammography Reconstructed from
Digital Breast Tomosynthesis and Full Field Digital Mammography for the Detection of T1 Breast Cancer.”
European Radiology. Epub 2015 Dec.
Zuckerman S, Conant E, Weinstein S. “Impact on Recall Rates Following Implementation of Synthesized 2D
Mammography in Digital Breast Tomosynthesis Screening.” paper presented at the annual meeting of the
Radiological Society of North America, Chicago, IL, December 2015).
Zuley M, Guo B, Catullo V, et al. “Comparison of Two-dimensional Synthesized Mammograms versus Original
Digital Mammograms Alone and in Combination with Tomosynthesis Images.” Radiology. 2014 Jun;271(3):664-71.
Skaane P, Bandos AI, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically
reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital
mammographic images. Radiology. 2014;271(3):655-63.
Genius™ 3D MAMMOGRAPHY™ exams are only available on the Selenia® Dimensions® breast tomosynthesis system by Hologic.
In Australia a 3D MAMMOGRAPHY™ exam is typically used as a diagnostic mammogram, usually performed at private radiology clinics and hospitals for high risk patients or women with abnormalities or symptoms, e.g. a lump or other suspicious finding. A GP or surgeon referral is required detailing clinical indications.
Hologic (Australia) Pty Ltd, Level 4, 2-4 Lyon Park Rd, Macquarie Park NSW 2113. Tel. +61 2 9888 8000. ABN 95 079 821 275.
Genius Customer Centre
Genius Customer Centre - Password reset
Genius Customer Centre
Thank you for submitting your request for a password.
Once we verify your details we will email your login details to you.
Please allow 1-2 working days to receive your login information.
Genius™ 3D MAMMOGRAPHY™
Customer Centre Usage Agreement
Contingent upon the limited use of the Image(s) and Templates contained
within the Genius™ 3D MAMMOGRAPHY™ Customer Centre provided by
Hologic, Inc. and affiliates (together “Hologic”), you are hereby authorized
to use, reproduce and distribute the contents provided:
You agree to credit any product Images as having been provided
‘courtesy of HOLOGIC, Inc. and affiliates’.
You agree that whenever you use a Hologic trademark, product name,
graphic or Image, you will attach a proper trademark attribution
notification to the foremost reference;
You warrant and guarantee that you shall use the Images and Templates
only in promotion of HOLOGIC, Inc. products used within your practice;
You warrant and guarantee that you shall not modify any Image except as
expressly consented to in writing by HOLOGIC;
You warrant and guarantee that you shall not utilize the Images or
Templates in any manner that could reasonably be foreseen to disparage
or cause disrepute to HOLOGIC and you shall provide immediate notice
to HOLOGIC in the event you become aware of any such use;
You acknowledge and agree that, while at the time of publication,
HOLOGIC endeavors to make all materials accurate and regulatory
compliant, HOLOGIC makes no representations or warranties regarding
the information provided;
You warrant and guarantee that you shall not license, transfer, or sell the
Images and Templates or any copies of the Images and Templates to any
person or entity; and
You release HOLOGIC, its successors, assigns, licensees, employees,
agents and representatives from any and all claims arising from your use
of the Images and Templates.
Any use of the Images and Templates must comply with all regulatory
approvals, laws and Government regulations where applicable.
HOLOGIC may terminate this agreement at any time, for any reason, with
immediate effect upon notice to you at the address provided below. Upon
termination of this agreement, you shall immediately cease reproducing,
distributing or otherwise utilizing the Images and Templates and shall
return all copies of the Images and Templates to HOLOGIC.
Arbitration, Choice of Law and Enforcement. Any controversy or claim
arising out of or related to this Agreement will be settled by binding
arbitration, by a single arbitrator, administered by the Australian Arbitration
Entity and judgment on the award rendered by the arbitrator may be
entered in any court having jurisdiction thereof. Any arbitration under this
Agreement will be held in Sydney, Australia and the arbitrator shall have no
authority to award punitive, consequential, or other damages not measured
by the prevailing Party’s actual damages. Each Party will bear its own costs
and expenses and an equal share of the arbitrators’ and administrative
fees of arbitration. This Section and this Agreement will be governed
by and interpreted in accordance with the laws of Australia. If any of the
provisions of this Section or this Agreement are held to be invalid, illegal
or unenforceable, the validity, legality, and enforceability of the remaining
provisions will not be affected or impaired.